Monobody-Mediated Alteration of Lipase Substrate Specificity

Area of Science:

• Enzyme engineering and biocatalysis
• Protein engineering and synthetic biology

Background:

• Controlling enzyme catalytic properties is crucial for chemistry and biotechnology.
• A novel strategy using proxy monobodies (synthetic binding proteins) was developed to alter enzyme specificity.
• This strategy modulates the specificity of unmodified enzymes.

Purpose of the Study:

• To examine the broader applicability of the proxy monobody strategy.
• To apply the strategy to Candida rugosa lipase 1 (CRL1), an enzyme with a tunnel-like substrate binding site.

Main Methods:

• Employed proxy monobodies to modulate the substrate specificity of CRL1.
• Identified specific proxy monobodies capable of restricting CRL1's substrate range.

Main Results:

• Successfully identified proxy monobodies that restricted the substrate specificity of CRL1.
• CRL1's specificity was successfully narrowed toward short-chain fatty acids.

Conclusions:

• The proxy monobody strategy is applicable to enzymes with diverse substrate binding site architectures.
• This approach holds promise for versatile enzyme engineering and biotechnology applications.